Insmed Inc (INSM)
68.15
-0.17
(-0.25%)
USD |
NASDAQ |
Nov 04, 16:00
68.45
+0.30
(+0.44%)
After-Hours: 20:00
Insmed Total Liabilities (Quarterly): 1.570B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.570B |
| June 30, 2024 | 1.771B |
| March 31, 2024 | 1.624B |
| December 31, 2023 | 1.662B |
| September 30, 2023 | 1.614B |
| June 30, 2023 | 1.595B |
| March 31, 2023 | 1.562B |
| December 31, 2022 | 1.568B |
| September 30, 2022 | 1.025B |
| June 30, 2022 | 1.009B |
| March 31, 2022 | 1.033B |
| December 31, 2021 | 833.04M |
| September 30, 2021 | 806.93M |
| June 30, 2021 | 698.73M |
| March 31, 2021 | 490.76M |
| December 31, 2020 | 520.27M |
| September 30, 2020 | 483.65M |
| June 30, 2020 | 480.05M |
| March 31, 2020 | 469.82M |
| December 31, 2019 | 480.62M |
| September 30, 2019 | 459.08M |
| June 30, 2019 | 446.21M |
| March 31, 2019 | 451.78M |
| December 31, 2018 | 396.29M |
| September 30, 2018 | 370.11M |
| Date | Value |
|---|---|
| June 30, 2018 | 353.60M |
| March 31, 2018 | 338.30M |
| December 31, 2017 | 100.99M |
| September 30, 2017 | 84.90M |
| June 30, 2017 | 82.20M |
| March 31, 2017 | 78.98M |
| December 31, 2016 | 83.47M |
| September 30, 2016 | 58.82M |
| June 30, 2016 | 49.12M |
| March 31, 2016 | 45.24M |
| December 31, 2015 | 44.86M |
| September 30, 2015 | 46.74M |
| June 30, 2015 | 43.17M |
| March 31, 2015 | 41.29M |
| December 31, 2014 | 44.63M |
| September 30, 2014 | 36.18M |
| June 30, 2014 | 38.56M |
| March 31, 2014 | 34.88M |
| December 31, 2013 | 33.17M |
| September 30, 2013 | 32.82M |
| June 30, 2013 | 33.54M |
| March 31, 2013 | 35.41M |
| December 31, 2012 | 32.68M |
| September 30, 2012 | 15.84M |
| June 30, 2012 | 16.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
469.82M
Minimum
Mar 2020
1.771B
Maximum
Jun 2024
1.065B
Average
1.017B
Median
Total Liabilities (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 20.47M |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Eli Lilly and Co | 61.29B |
| Bioventus Inc | 603.11M |
| Entrada Therapeutics Inc | 152.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.053B |
| Shareholders Equity (Quarterly) | 483.42M |
| Debt to Equity Ratio | 1.975 |
| Current Ratio | 6.365 |
| Net Debt Paydown Yield | 0.28% |